Individualized luteal phase support in frozen-thawed embryo transfer after intramuscular progesterone administration might rectify live birth rate.
Autor: | Boynukalin FK; Infertility Department, Bahçeci Fulya IVF Center, Istanbul, Türkiye.; Department of Obstetrics and Gynecology, Faculty of Medicine, Üsküdar University, Istanbul, Türkiye., Tohma YA; Infertility Department, Bahçeci Ankara IVF Center, Ankara, Türkiye.; Department of Obstetrics and Gynecology, Faculty of Medicine, Atılım University, Ankara, Türkiye., Yarkıner Z; Department of Basic Sciences and Humanities, Faculty of Arts and Sciences, Cyprus International University, Nicosia, Cyprus., Gultomruk M; Infertility Department, Bahçeci Fulya IVF Center, Istanbul, Türkiye., Bozdag G; Infertility Department, Bahçeci Fulya IVF Center, Istanbul, Türkiye., Ozkavukcu S; Infertility Department, Bahçeci Ankara IVF Center, Ankara, Türkiye., Bahçeci M; Infertility Department, Bahçeci Fulya IVF Center, Istanbul, Türkiye., Demir B; Infertility Department, Bahçeci Ankara IVF Center, Ankara, Türkiye. |
---|---|
Jazyk: | angličtina |
Zdroj: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Jun 28; Vol. 15, pp. 1412185. Date of Electronic Publication: 2024 Jun 28 (Print Publication: 2024). |
DOI: | 10.3389/fendo.2024.1412185 |
Abstrakt: | Background: The serum P concentrations are suggested to have an impact on pregnancy outcome. However there is no consensus about the optimal progesterone cut-off during the luteal phase. Few studies evaluated the effectiveness of a "rescue protocol" for low serum P concentrations and most of these studies used vaginal progesterone administration. There is paucity of data on the effectiveness of rescue protocol using intramuscular progesterone (IM-P) in frozen-thawed embryo transfer (FET). Methods: This study is a retrospective cohort study included 637 single or double blastocyst FETs with artificially prepared endometrium receiving 100 mg IM progesterone (P) after incremental estrogen treatment. Serum P concentrations were evaluated using blood samples obtained 117-119 hours after the first IM-P administration and 21 ± 2 hours after the last IM-P administration. Patients with serum P concentrations <20.6 ng/ml on the ET day were administrated 400 mg vaginal progesterone for rescue. Results: Demographic and cycle characteristics were similar between patients receiving rescue vaginal P (embryo transfer (ET)-day P concentration < 20.6 ng/ml) and patients who did not need rescue vaginal P (ET-day P concentration ≥ 20.6 ng/ml). Clinical pregnancy, miscarriage, and live birth rates were similar between two groups: 52.9%(45/85) vs 59.6%(326/552), p=0.287; 11.1%(5/45) vs 14.1%(46/326), p=0.583; and 47.1%(40/85) vs 50.7%(280/552), p=0.526, respectively. Logistic regression analysis revealed that the female age (p = 0.008, OR=0.942, 95% CI = 0.902-0.984) and embryo quality (ref: good quality for moderate: p=0.02, OR=0.469, 95% CI =0.269-0.760; for poor: p=0.013, OR= 0.269, 95% CI = 0.092-0.757) were independent variables for live birth. Following rescue protocol implementation, ET-day P concentration was not a significant predictor of live birth. Conclusions: Rescue vaginal P administration for low ET day serum P concentrations following IM-P yields comparable live birth rates. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2024 Boynukalin, Tohma, Yarkıner, Gultomruk, Bozdag, Ozkavukcu, Bahçeci and Demir.) |
Databáze: | MEDLINE |
Externí odkaz: |